ADIAL PHARMACEUTICALS, INC. - FORM S-1/A - EX-23.1 - CONSENT OF FRIEDMAN LLP

Attached files

file	filename
EX-4.22 - FORM OF WARRANT AGENT AGREEMENT - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex4-22_adialpharm.htm
EX-10.31 - SECURITY AGREEMENT DATED JUNE 6, 2018 - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex10-31_adialpharm.htm
EX-10.30 - SECURITIES PURCHASE AGREEMENT DATED JUNE 6, 2018 - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex10-30_adialpharm.htm
EX-5.1 - OPINION OF GRACIN & MARLOW, LLP - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex5-1_adialpharma.htm
EX-4.25 - AMENDMENT NO. 1 TO 18% SENIOR SECURED PROMISSORY NOTE - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex4-25_adialpharm.htm
EX-4.24 - NOTE ISSUED ON JUNE 6, 2018 IN THE PRINCIPAL AMOUNT OF $325,000 - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex4-24_adialpharm.htm
EX-4.23 - FORM OF CERTIFICATED WARRANT - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex4-23_adialpharm.htm
EX-4.21 - STOCK PURCHASE WARRANT - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex4-21_adialpharm.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - ADIAL PHARMACEUTICALS, INC.	fs12017a5ex1-1_adialpharma.htm
S-1/A - AMENDMENT NO. 5 TO FORM S-1 - ADIAL PHARMACEUTICALS, INC.	fs12017a5_adialpharma.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the inclusion in this Amendment No. 5 to the Registration Statement on Form S-1 (File No. 333-220368) of our report dated April 13, 2018, which includes an explanatory paragraph as to the company’s ability to continue as going concern, with respect to the financial statements of Adial Pharmaceuticals, Inc. as of December 31, 2017 and 2016 and for the years then ended. We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.

/s/ Friedman LLP

East Hanover, New Jersey

June 8, 2018

ADIAL PHARMACEUTICALS, INC. - FORM S-1/A - EX-23.1 - CONSENT OF FRIEDMAN LLP - June 8, 2018

Attached files

ADIAL PHARMACEUTICALS, INC. Reports